TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,037,748 | -0.2% | 160,110 | +0.4% | 0.00% | – |
| Q2 2023 | $6,050,821 | +329.8% | 159,526 | +175.6% | 0.00% | – |
| Q1 2023 | $1,407,958 | -57.4% | 57,893 | -49.1% | 0.00% | – |
| Q4 2022 | $3,304,346 | +88.8% | 113,786 | +94.9% | 0.00% | – |
| Q3 2022 | $1,750,000 | -5.5% | 58,382 | +14.1% | 0.00% | – |
| Q2 2022 | $1,851,000 | -15.2% | 51,182 | +1.4% | 0.00% | – |
| Q1 2022 | $2,184,000 | -16.5% | 50,482 | -3.3% | 0.00% | – |
| Q4 2021 | $2,615,000 | -19.8% | 52,194 | +1.9% | 0.00% | – |
| Q3 2021 | $3,259,000 | -9.1% | 51,220 | +2.8% | 0.00% | – |
| Q2 2021 | $3,585,000 | -1.5% | 49,820 | +0.9% | 0.00% | – |
| Q1 2021 | $3,641,000 | +31.3% | 49,372 | +30.7% | 0.00% | – |
| Q4 2020 | $2,773,000 | +600.3% | 37,772 | +422.6% | 0.00% | – |
| Q3 2020 | $396,000 | -5.7% | 7,228 | +14.4% | 0.00% | – |
| Q2 2020 | $420,000 | +9.4% | 6,319 | +0.8% | 0.00% | – |
| Q1 2020 | $384,000 | -30.3% | 6,270 | 0.0% | 0.00% | – |
| Q4 2019 | $551,000 | +90.7% | 6,270 | +64.0% | 0.00% | – |
| Q3 2019 | $289,000 | -11.6% | 3,824 | 0.0% | 0.00% | – |
| Q2 2019 | $327,000 | -22.9% | 3,824 | -2.5% | 0.00% | – |
| Q1 2019 | $424,000 | +15.8% | 3,924 | -9.3% | 0.00% | – |
| Q4 2018 | $366,000 | -15.9% | 4,324 | -2.3% | 0.00% | – |
| Q3 2018 | $435,000 | +64.8% | 4,424 | +66.6% | 0.00% | – |
| Q1 2018 | $264,000 | -59.6% | 2,655 | -57.6% | 0.00% | – |
| Q4 2017 | $654,000 | -97.2% | 6,266 | -97.0% | 0.00% | -100.0% |
| Q3 2017 | $23,192,000 | -0.6% | 205,803 | -1.1% | 0.00% | 0.0% |
| Q2 2017 | $23,323,000 | -5.3% | 208,164 | -1.4% | 0.00% | 0.0% |
| Q1 2017 | $24,632,000 | +13.6% | 211,226 | +2.5% | 0.00% | 0.0% |
| Q4 2016 | $21,686,000 | -1.4% | 206,012 | +3.5% | 0.00% | 0.0% |
| Q3 2016 | $22,001,000 | -20.0% | 199,079 | +5.4% | 0.00% | -33.3% |
| Q2 2016 | $27,492,000 | +100.7% | 188,822 | +97.4% | 0.00% | +200.0% |
| Q1 2016 | $13,699,000 | +6.7% | 95,637 | +15.2% | 0.00% | 0.0% |
| Q4 2015 | $12,835,000 | +3495.2% | 83,032 | +3217.3% | 0.00% | – |
| Q3 2015 | $357,000 | -5.3% | 2,503 | -4.6% | 0.00% | – |
| Q2 2015 | $377,000 | -5.8% | 2,625 | -7.5% | 0.00% | – |
| Q1 2015 | $400,000 | -18.9% | 2,838 | -14.8% | 0.00% | – |
| Q4 2014 | $493,000 | +4.0% | 3,330 | +8.2% | 0.00% | – |
| Q3 2014 | $474,000 | -4.0% | 3,079 | -12.4% | 0.00% | – |
| Q2 2014 | $494,000 | -4.4% | 3,516 | -24.5% | 0.00% | – |
| Q1 2014 | $517,000 | +27.3% | 4,658 | +13.5% | 0.00% | – |
| Q4 2013 | $406,000 | +76.5% | 4,103 | +35.1% | 0.00% | – |
| Q3 2013 | $230,000 | – | 3,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |